Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical tacrolimus in dermatology.

I S Nasr1

  • 1Consultant Dermatologist, Scunthorpe General Hospital, Scunthorpe, North Lincolnshire, UK. isinasr@quista.nct

Clinical and Experimental Dermatology
|June 9, 2000
PubMed
Summary

Topical tacrolimus effectively treats atopic dermatitis and other inflammatory skin conditions, unlike topical cyclosporin A which shows limited efficacy. Further research is needed for psoriasis treatment with topical tacrolimus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Comment on 'Real-World Outcomes of Stapokibart-Based Combination Therapy for Bullous Pemphigoid: A Single-Center Retrospective Cohort': towards controlled comparisons, neurological profiling, and long-term follow-up.

Clinical and experimental dermatology·2026
Same journal

Comment on 'Long-term effectiveness of bimekizumab in plaque psoriasis: 2-year drug survival from a real-life multicenter Italian study'.

Clinical and experimental dermatology·2026
Same journal

Comment on 'Chromoblastomycosis in northern Taiwan from 2017 to 2024: unique characteristics'.

Clinical and experimental dermatology·2026
Same journal

Comment on 'The reliability and smallest detectable difference of the Severity of Alopecia Tool score in alopecia areata'.

Clinical and experimental dermatology·2026
Same journal

Comment on 'An open-label phase II study of bitopertin in adults and adolescents with erythropoietic protoporphyria or X-linked protoporphyria'.

Clinical and experimental dermatology·2026
Same journal

A peculiar xanthomatous eruption.

Clinical and experimental dermatology·2026

Area of Science:

  • Dermatology
  • Immunosuppression
  • Pharmacology

Background:

  • Tacrolimus and cyclosporin A are potent immunosuppressants used systemically for inflammatory skin diseases.
  • These drugs share similar side-effect profiles but differ in potency, with tacrolimus being significantly stronger.
  • Topical applications have been explored in clinical studies for various dermatological conditions.

Purpose of the Study:

  • To compare the efficacy of topical tacrolimus and cyclosporin A in treating inflammatory skin conditions.
  • To evaluate the therapeutic potential of topical tacrolimus in conditions beyond atopic dermatitis.

Main Methods:

  • Review of clinical studies investigating topical immunosuppressants.
  • Comparative analysis of efficacy data for topical tacrolimus versus topical cyclosporin A.
  • Assessment of topical tacrolimus use in conditions such as allergic contact dermatitis, lichen planus, and pyoderma gangrenosum.

Main Results:

  • Topical cyclosporin A demonstrates largely ineffective outcomes in clinical use.
  • Topical tacrolimus shows significant effectiveness in treating atopic dermatitis.
  • Topical tacrolimus has proven successful in allergic contact dermatitis, erosive mucosal lichen planus, and pyoderma gangrenosum.

Conclusions:

  • Topical tacrolimus is a viable and effective treatment for atopic dermatitis and other specific inflammatory dermatoses.
  • Topical cyclosporin A is generally ineffective for skin conditions.
  • Further clinical investigation is warranted to establish the efficacy of topical tacrolimus for psoriasis.

Related Experiment Videos